Literature DB >> 7534817

Molecular epidemiology of enterovirus outbreaks in Canada during 1991-1992: identification of echovirus 30 and coxsackievirus B1 strains by amplicon sequencing.

M A Drebot1, C Y Nguan, J J Campbell, S H Lee, K R Forward.   

Abstract

The relatedness of enteroviral isolates associated with two recent outbreaks in Canada was assessed using direct sequencing of amplicons derived from a large portion of the 5' nontranslated region (NTR) of the viral genome. The amplicons of 60 echovirus 30 isolates originating from seven different provinces in 1991 were found to share 99% or greater sequence identity. Recent coxsackievirus B1 isolates characterised in the same manner were identical to each other. When the 5' NTR sequence of these isolates was compared to prototype strains a difference of 11-15% in nucleotide composition was observed. These results indicate that the variability of nucleotide sequence found in 5' NTRs can be utilized to identify rapidly enteroviral strains associated with particular outbreaks and distinguish them from other strains and serotypes.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7534817     DOI: 10.1002/jmv.1890440406

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  10 in total

1.  Molecular epidemiology and genetic diversity of echovirus type 30 (E30): genotypes correlate with temporal dynamics of E30 isolation.

Authors:  M S Oberste; K Maher; M L Kennett; J J Campbell; M S Carpenter; D Schnurr; M A Pallansch
Journal:  J Clin Microbiol       Date:  1999-12       Impact factor: 5.948

2.  Molecular identification of enterovirus by analyzing a partial VP1 genomic region with different methods.

Authors:  G Palacios; I Casas; A Tenorio; C Freire
Journal:  J Clin Microbiol       Date:  2002-01       Impact factor: 5.948

3.  Genomic variations in echovirus 30 persistent isolates recovered from a chronically infected immunodeficient child and comparison with the reference strain.

Authors:  J L Bailly; M Chambon; C Henquell; J Icart; H Peigue-Lafeuille
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

4.  Typing of human enteroviruses by partial sequencing of VP1.

Authors:  M S Oberste; K Maher; D R Kilpatrick; M R Flemister; B A Brown; M A Pallansch
Journal:  J Clin Microbiol       Date:  1999-05       Impact factor: 5.948

Review 5.  Molecular typing of enteroviruses: current status and future requirements. The European Union Concerted Action on Virus Meningitis and Encephalitis.

Authors:  P Muir; U Kämmerer; K Korn; M N Mulders; T Pöyry; B Weissbrich; R Kandolf; G M Cleator; A M van Loon
Journal:  Clin Microbiol Rev       Date:  1998-01       Impact factor: 26.132

6.  Molecular detection of an importation of type 3 wild poliovirus into Canada from The Netherlands in 1993.

Authors:  M A Drebot; M N Mulders; J J Campbell; O M Kew; K Fonseca; D Strong; S H Lee
Journal:  Appl Environ Microbiol       Date:  1997-02       Impact factor: 4.792

7.  Laboratory diagnosis and genetic analysis of a family clustering outbreak of aseptic meningitis due to echovirus 30.

Authors:  Shufa Zheng; Hongyan Ye; Juying Yan; Guoliang Xie; Dawei Cui; Fei Yu; Yiyin Wang; Xianzhi Yang; Fangman Zhou; Yanjun Zhang; Xueli Tian; Yu Chen
Journal:  Pathog Glob Health       Date:  2016-09-19       Impact factor: 2.894

8.  Intratypic genome variability of echovirus type 30 in part of the VP4/VP2 coding region.

Authors:  K Gjøen; A L Bruu; I Orstavik
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

9.  Molecular classification of enteroviruses not identified by neutralization tests.

Authors:  Hideyuki Kubo; Nobuhiro Iritani; Yoshiyuki Seto
Journal:  Emerg Infect Dis       Date:  2002-03       Impact factor: 6.883

10.  Complete genome sequence analysis of human echovirus 30 isolated during a large outbreak in Guangdong Province of China, in 2012.

Authors:  Hong Xiao; Keyong Huang; Ling Li; Xianbo Wu; Li Zheng; Chengsong Wan; Wei Zhao; Changwen Ke; Bao Zhang
Journal:  Arch Virol       Date:  2013-08-29       Impact factor: 2.574

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.